Christine Isaacson

Christine Isaacson is an accomplished professional in technical operations and product management, currently serving as Product Lead at Sobi - Swedish Orphan Biovitrum AB (publ) since March 2022. With a robust background in Chemistry Manufacturing & Controls (CMC), Isaacson has held significant roles such as Director, CMC Drug Product Development Lead, and CMC Program Lead, where leadership of cross-functional development teams and strategic planning were key responsibilities. Prior to Sobi, experience at AstraZeneca included leadership roles in Technology and Design Transfer and as a Senior Process Engineer, contributing to the development of biologics at the Sweden BioManufacturing Centre. Additional experience spans consulting and validation engineering roles at Knightec AB and ProPharma Group, as well as analytical technologies at PDL BioPharma Inc. Christine Isaacson holds a Bachelor of Science degree in Genetics and Cell Biology from the University of Minnesota.